Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl)borate, 98%, 100mg

acido m-toluico, 98%, per sintesi, 250 g, confezione in plastica.

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridine, 95.0%, 25g

N1,N1-DIMETHYLPROPANE-1,2-DIAMINE, 97.0%, 10g

1-(Dimethylamino)-3-[2-(3-methoxyphenethyl)phenoxy]-2-propanol Hydrochloride>98.0%(HPLC)(T)200mg

Bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate, 95%, 5g

(S)-Methyl 2-aminopentanoate hydrochloride, 95.0%, 100g

1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1R,2R)-2-(dimethylamino)cyclohexyl)thiourea, 97%, 1g

2,4-DICHLORO-8-METHYLQUINOLINE, 95.0%, 100mg

tert-Butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 10g

3,4-Diacetoxybenzonitrile, 1g

1,4-Bis-[4-(3-acryloyloxypropyloxy)benzoyloxy]-2-methylbenzene, 98%, 100g

5,6,7,8-Tetrahydro-1,6-naphthyridine hydrochloride, 95.0%, 25g